EVIDENCE-BASED MENTAL HEALTH
Iron supplementation in non-anaemic women did not improve pregnancy outcomes and may be harmful to both mother and baby
| The first 150 words of the full text of this article appear below. |
STUDY DESIGN
randomised placebo-controlled trial.
unclear.*
blinded (patients and healthcare providers).*
STUDY QUESTION
6 prenatal clinics in Iran.
750 non-smoking women 17–35 years of age (mean age 26 y) with a singleton pregnancy in the early second trimester (mean 13 wks), haemoglobin concentration
13.2 (mean 14.0) g/dl, body mass index 19.8–26 kg/m2, no history of threatened abortion in the current pregnancy, and no disease related to polycythaemia such as asthma or chronic hypertension.
ferrous sulphate, 150 mg (50 mg of elemental iron) (n = 375), or placebo (n = 375) once daily throughout pregnancy. All women received folic acid, 1 mg/day, but were not allowed to take other vitamin or mineral supplements.
small for gestational age (SGA, <10th percentile) infant, hypertensive disorder, premature labour, caesarean delivery for obstetrical reasons, Apgar score, birthweight, and perinatal mortality.
6 weeks after delivery.
97% (intention-to-treat analysis). 2 women in the placebo group were withdrawn because of the
Artemisia Prenatal Diagnosis Centre, Rome, Italy
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



